SAHaRA: A Randomized Controlled Trial

Completed · Not applicable

Conditions studied: Subarachnoid Hemorrhage, Aneurysmal

In brief

The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.

Key facts

Study ID
NCT03309579
Run by
Ottawa Hospital Research Institute
People needed
742
Starts
2018-02-12
Expected to finish
2024-08-22
Last updated by the study team
2024-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.